International Journal of Dermatology 1992: Vol 31 Index

15 Pages·1992·2.8 MB·English

CUMULATIVE INDEX: VOLUME 31
ie
SUBJECT INDEX American Leprosy Mission Consensus Basal cell carcinoma, 398-399, 635-638
Development Conference, Basement membrane zone,
Acantholytic agents, 722-724 891-892 immunofluorescence, 296-297
ACE-inhibitors, 33-36 American Rheumatism Association, 68 Bath oils, 313
Aminophyllin, 370-371 Beau's lines, 455
Acne
adolescent in women, 118 Amyloidosis Bedding, for toxic epidermal necrolysis,
extensive macular, 277-278 755
etiology of, 577
primary localized cutaneous, 94 Behcet’s disease, 521-522, 571-572
Acquired immunodeficiency syndrome
Anderson, Sir Thomas McCall, 733-738 645-646
see AIDS
Acquired perforating disease, 117-118, Angiodermatitis, 786-787 Benign neonatal hemangiomatosis,
201-204 Anthralin, 67, 126-129, 841-842
Beriberi, 724
Antibiotics, 461, 893
Actinic prurigo, 372-373, 599-600
“Big foot” disease, 851
Acute adult T-cell leukemia/lymphoma, Antigen mapping, 38
Biliary cirrhosis, 392, 393-394
582-586 Antihistamines, 355
Biopsy
Acute febrile neutrophilic dermatosis, Antimalarials, 458
differentiation of bullous pemphigoid
165, 297-298, 598-599, Antimetabolites, 461
from epidermolysis bullosa
645-648, 670-671 Antimicrobials, 758-759 acquisita, 37-40
Acute graft vs. host disease, 270 Antineoplastics, 842
for immunofluorescence staining,
Acute myelogenous leukemia, 598-599 Antiphospholipid antibodies, 588-589 265-266
Acute phase response, 632-634 Aplasia, 426-428 liver, 404-408
Acute porphyrias, 532 Apocrine gland, 377 Birbeck granules, 164
Acute wounds, 13 Argentina, history of dermatology in, Blaschko’s lines, 351
Adoptive transfer, 470 881-888 Bleaching agents, 315-316
Advertising, 144 Argon laser, 602-603 Bleomycin, 770
Aging, 391 Arm, elephantiasis of, 848 Bloom’s syndrome, 311
AIDS (acquired immunodeficiency Ascher’s syndrome, 710-712 Board exams, 68
syndrome) Ascites, 451 Bone metastases, 637-638
and bacillary angiomatosis, 19-23 Ascorbic acid see Vitamin (€ Book Reviews
detection of autoimmunity Ashy dermatosis, 87-93 Atlas of Cutaneous Laser Surgery, 452
parameters, 113-115 Asociacion Argentina de Dermatologia, Atlas of Infections of the Skin, 374
and eosinophilic pustular folliculitis, 884, 887 Atlas of Skin Cancer, 452
193-194
Ataxia-telangiectasia, 310-311 Clinical and Experimental Approaches
and Kaposi’s sarcoma, 471, 598 Atopic dermatitis, 521, 611-613 to Dermal and Epidermal
and syphilis, 156 Australia Repair, 145
see also HIV infection multiple basal cell carcinoma in, Color Atlas of Sexually Transmitted
Alginates, 12 635-636 Diseases, 374
Alkylating agents, 461 squamous cell carcinoma in, 492-493 Dermatology, 69
Allergy, food, 611-613 Autoimmune chronic active hepatitis, 393 Electrosurgery of the Skin, 69
Aloe vera, 372 Autoimmune disorders, 381-382 Enfermedades de la Boca, 374
Alopecia, 319, 556 bullous, 687-690 Genital Papillomavirus Infections, 374
see also specific disorders Leprosy: Medicine in the Tropics, 600
and cutis verticis gyrata, 671-672
female androgenetic, 800-804 Autologous minigrafting, 314-315 Local Anesthesia for Dermatologic
Surgery, 145
hormonal status in postmenopausal Azathioprine, 873-874
Traditional Indian Dermatology—
androgenetic, 858-859
Concepts of Past and Present,
and occult syringoma, 437-438 673
Alopecia areata, 103-105, 186-189, 455 Bacillary angiomatosis, 19-23, 615-616 Tropical Mycoses, 145
Alopecia mucinosa see Follicular mucinosis Baldness see Alopecia; Hair Year Book of Dermatology 1991, 145
Alopecia universalis, 513-516 Balifia, Pedro L., 882 Borrelia burgdorferi, 507-508, 820
896
CUMULATIVE INDEX: VOLUME 31
ie
SUBJECT INDEX American Leprosy Mission Consensus Basal cell carcinoma, 398-399, 635-638
Development Conference, Basement membrane zone,
Acantholytic agents, 722-724 891-892 immunofluorescence, 296-297
ACE-inhibitors, 33-36 American Rheumatism Association, 68 Bath oils, 313
Aminophyllin, 370-371 Beau's lines, 455
Acne
adolescent in women, 118 Amyloidosis Bedding, for toxic epidermal necrolysis,
extensive macular, 277-278 755
etiology of, 577
primary localized cutaneous, 94 Behcet’s disease, 521-522, 571-572
Acquired immunodeficiency syndrome
Anderson, Sir Thomas McCall, 733-738 645-646
see AIDS
Acquired perforating disease, 117-118, Angiodermatitis, 786-787 Benign neonatal hemangiomatosis,
201-204 Anthralin, 67, 126-129, 841-842
Beriberi, 724
Antibiotics, 461, 893
Actinic prurigo, 372-373, 599-600
“Big foot” disease, 851
Acute adult T-cell leukemia/lymphoma, Antigen mapping, 38
Biliary cirrhosis, 392, 393-394
582-586 Antihistamines, 355
Biopsy
Acute febrile neutrophilic dermatosis, Antimalarials, 458
differentiation of bullous pemphigoid
165, 297-298, 598-599, Antimetabolites, 461
from epidermolysis bullosa
645-648, 670-671 Antimicrobials, 758-759 acquisita, 37-40
Acute graft vs. host disease, 270 Antineoplastics, 842
for immunofluorescence staining,
Acute myelogenous leukemia, 598-599 Antiphospholipid antibodies, 588-589 265-266
Acute phase response, 632-634 Aplasia, 426-428 liver, 404-408
Acute porphyrias, 532 Apocrine gland, 377 Birbeck granules, 164
Acute wounds, 13 Argentina, history of dermatology in, Blaschko’s lines, 351
Adoptive transfer, 470 881-888 Bleaching agents, 315-316
Advertising, 144 Argon laser, 602-603 Bleomycin, 770
Aging, 391 Arm, elephantiasis of, 848 Bloom’s syndrome, 311
AIDS (acquired immunodeficiency Ascher’s syndrome, 710-712 Board exams, 68
syndrome) Ascites, 451 Bone metastases, 637-638
and bacillary angiomatosis, 19-23 Ascorbic acid see Vitamin (€ Book Reviews
detection of autoimmunity Ashy dermatosis, 87-93 Atlas of Cutaneous Laser Surgery, 452
parameters, 113-115 Asociacion Argentina de Dermatologia, Atlas of Infections of the Skin, 374
and eosinophilic pustular folliculitis, 884, 887 Atlas of Skin Cancer, 452
193-194
Ataxia-telangiectasia, 310-311 Clinical and Experimental Approaches
and Kaposi’s sarcoma, 471, 598 Atopic dermatitis, 521, 611-613 to Dermal and Epidermal
and syphilis, 156 Australia Repair, 145
see also HIV infection multiple basal cell carcinoma in, Color Atlas of Sexually Transmitted
Alginates, 12 635-636 Diseases, 374
Alkylating agents, 461 squamous cell carcinoma in, 492-493 Dermatology, 69
Allergy, food, 611-613 Autoimmune chronic active hepatitis, 393 Electrosurgery of the Skin, 69
Aloe vera, 372 Autoimmune disorders, 381-382 Enfermedades de la Boca, 374
Alopecia, 319, 556 bullous, 687-690 Genital Papillomavirus Infections, 374
see also specific disorders Leprosy: Medicine in the Tropics, 600
and cutis verticis gyrata, 671-672
female androgenetic, 800-804 Autologous minigrafting, 314-315 Local Anesthesia for Dermatologic
Surgery, 145
hormonal status in postmenopausal Azathioprine, 873-874
Traditional Indian Dermatology—
androgenetic, 858-859
Concepts of Past and Present,
and occult syringoma, 437-438 673
Alopecia areata, 103-105, 186-189, 455 Bacillary angiomatosis, 19-23, 615-616 Tropical Mycoses, 145
Alopecia mucinosa see Follicular mucinosis Baldness see Alopecia; Hair Year Book of Dermatology 1991, 145
Alopecia universalis, 513-516 Balifia, Pedro L., 882 Borrelia burgdorferi, 507-508, 820
896
Subject Index
Breast Chronic cutaneous leishmaniasis, Cylindroma, 642-644
chromomycosis of, 184 $62-563, 565-567 Cyproterone acetate, 319
elephantiasis of, 848 Chronic idiopathic urticaria, 29, 3 Cytokeratin, 30-32
implants, 195 Chronic lymphocytic leukemia, 672 Cytokines, 154
Brilliant green, 210-212 Chronic renal failure, 117-118, 860-862
Brill-Zinsser disease, 826 Chronic venous insufficiency, 833-834,
836-837
Bruno of Longoburgo, 573
Darier’s disease see Keratosis follicularis
Bulgarian dermatology, 60-65, 295 Cicatricial pemphigoid, 296-297, 688-689
Dartres, 617
Bullous diseases, 42-45, 687-690 Cirrhosis, 392, 393-394
Debridement, for toxic epidermal
Clofazimine, 591-593
Bullous pemphigoid, 37-40, 498-500, 689 necrolysis, 756
Cockayne’s syndrome, 311
Burns Decision tree, 404-408
Collagen, 152-153, 154, 467-469, 522
cutaneous thermal, 46-48 Decubitus ulcers, 412
Coloring agents, non-melanin, 230-231
partial thickness, 13-14
Degos’ syndrome see Malignant atrophic
skin substitutes in full thickness, 14 Common dermatoses, 555-556
papulosis
Condyloma accuminata, 98, 894
Burn unit, for toxic epidermal necrolysis, Demodex folliculorum, 718-719
755 Condyloma latum, 597 Dermal connective tissue, 149-154
Buruli ulcer, 25-26, 744 Connective tissue, 149-154 Dermal cylindroma, 642-644
Contact dermatitis, 853-854
Dermatitis herpetiformis, 42-45
Cordoba (Arg.), 884-885
Dermatobia hominis larvae, 657-659
Corrientes (Arg.), 886
Calcinosis of scrotum, 75-79 Dermatology
Corticosteroids
Calcipotriol, 549-550 and advertising, 144
intralesional, 233-234
Cancer, 867 in Argentina, 881-888
for psoriasis, 842
see also Malignancies; Tumors; in Bulgaria, 60-65, 295
topical, 241, 264
specific types of cancer cyclosporine in, 520-523
for toxic epidermal necrolysis, 758
Candida albicans, 700-702, 783-785 laser use in, 601-607
Cosmetics, 229-230
Canine pruritus, 236 mercury in, 159
Cowper, William, 361-363
Captopril, 722-724 in Persian Gulf War, 494-497
Crocker, Henry Radcliffe, 446-450
Carbohydrate metabolism, 381 and pharmaceutical industry, 144
Crotamiton, 357-358
Carbon dioxide laser, 605-606 relevance of current T-lymphocyte
ryosurgery, 887
Caries spine, 505-506 studies, 157-158
ryotherapy, 771
Carotenoderma, 50-51 research at National Student Research
sryptococcosis, 279-280 Forum, 866-867
Carotenoids, 462
Cats, 228 utaneous erythema, 206-209 scope of, 416 421
utaneous horn, 142-144, 369-370 surgical student electives, 288-290,
Cat scratch disease, 615-616
utaneous leishmaniasis, 562-563, 472-473
CI°8+ peripheral T-cell lymphoma,
565-570 tartar emetic in, 269
624-628
utaneous lupus erythematosus, Dermatomyositis, 426-428, 517-519, 867
Cefadroxil, 131-133
260-263, 265-268
Cellul6i6,t 5i98s-5,9 9 ‘utaneous lymphoma, 789-790 Dermatophy7t2o0s-i7s2,1 122-125, 247-248,
Cephalexin, 359-360, 443
‘utaneous melanoma, 331-335 Dexamethasone-cyclophosphamide pulse
Cerebrospinal fluid, 670-671 utaneous mucinosis, 649-651 therapy, 875-877
Cervical adenocarcinoma, 819
Cutaneous mycoses, 58-59 Diaper dermatitis, 700-702
Cetrimide-chlorhexidine cream, 359-360
Jutaneous myiasis, 657-659 Diffuse alopecia, 319
Cheilitis, 373
utaneous porphyrias, 532-534 Diffuse cutaneous leishmaniasis, 568-570
Chemotherapy, 460-462, 891-892 ‘utaneous sarcoidosis, 385-388 Direct immunofluorescence, 38, 753 >
Chest wall, 273-275
‘utaneous tuberculosis, 110-111, 50S—506 Discoid lupus erythematosus, 182-183
China, psoriatic research in, 840-843 utaneous tumors, 377-378 Dogs, 236, 804
Chloasma see Melasma
Cuticle removers, 677, 678 Donovanosis, 244-246, 696-698
Cholangitis, 392, 394 Cutis marmorata telangiectasia congenita, Dressings
Chromoblastomycosis, 726, 729, 805-811 249-252, 311, 377 microwave and elastic for
Chromomycosis, 184 Cutis verticis gyrata, 671-672 lymphedema, 660-663
Chromosomal mosaicism, 345-347 Cuzco (Peru), 560-561 for toxic epidermal necrolysis, 756-75
Chronic active hepatitis, 392, 393 Cyclosporine, 513-523, 895 wound, 10-15
897
International Journal of Dermatology
Vol. 31, No. 12, December 1992
Driving, and senior citizens, 497 Facial pyogenic granuloma-like lesions, Gnathostomiasis, 175-177
Drugs see Pharmacologic agents; specific 199-200 Goddard Space Flight Center, 220
drugs Factitious purpura, 167-168 Gottron’s sign, 426
Dry skin, 313 Fatal disseminated Mycobacterium Grafts
Dyschromia, nail, 454 marinum, 286-287 donor sites, 13
Dysplastic nevi, 327-329, 331-335 FDA see Food and Drug Administration
dressings for, 14
Febrile neutrophilic dermatosis, 645-648 Graft versus host disease, 270, 509-510
Fibronectin antibodies, 190-192 Granuloma annulare, 55-56, 371-372,
Eccrine gland, 377 Fifth National Congress of Bulgarian 672, 745-746, 819
Eccrine hidradenitis, 433-434 Dermatologists, 295-296 familial, 818
Filarial elephantiasis, 845-849
Ectoparasites, 94 Granuloma inguinale see Donovanosis
Filipino elderly, 196-198
Eczema, 736-737, 778 Granulomas, 353-354, 483
herpeticum, 298-299 Fish oil, 863 Granulomatous cells, 165-166
Edema, 206-209, 377 §-Fluorouracil, 317, 770-771 Granulomatous rosacea, 718-719
Editorial, A6é Florid cutaneous disease, 582-586 Graves’ disease, 431-432
Editorial note, 165, 367 Fluconazole shampoo, 664-665 Greco, Nicolas, 882
Educational Commission for Foreign Fluorouracil, 317 77( * 771 Greenland, psoriasis in, 863
Medical Graduates, 798-799 Foams, 12 Groin studies, 784
Ehrlichiosis, 415 Follicular mucinosis, 441-442, 791-792 Group interaction, 242
Elastic dressings, 660-663 Fonsecaea pedrosoi, 805-811 Gynecologic disorders, 331-335
Electron microscopy, 481 Food allergy, 611-613
Electrotrichogenesis, 878-880 Food and Drug Administration (FDA),
Elephantiasis, 845-851 691-692
Hair
Elephantiasis nostras, 849-851 Food deficiency diseases, 724, 844
changes during pregnancy, 376
Emotional support, for toxic epidermal Foot web studies, 784
follicle nevus, 578-580
necrolysis, 759-760 Foreign body granulomas, 353-354
graying, 455
Enalapril, 722-724 Fungal infection, 558
and HIV infection, 455
Endemic typhus, 826-829 Fusarium leg ulcers, 511-512
loss, 130, 376
Endothelial hyperplasia, 713-714
see also Alopecia
Entre Rios (Arg.), 886
Headache, 671-672
Entropion, 710-712 Generalized essential telangiectasia, 309
Heart transplant, 52-54
Eosinophilia-myalgia syndrome, 223-227, Genetics, and psoriatic research, 841
384 Heavy metals, 460
Genital herpes, 399
Eosinophilic cellulitis, 429-430, 672 Hemangiomatosis,
Genital human papillomavirus infections,
Eosinophilic fasciitis, 57 Hepatic porphyrias,
682-685
Eosinophilic pustular folliculitis, 193-194 Hepatitis, 392, 393
carcinogenesis, 684-685
Epidemic typhus, 823-826 Hepatocellular carcinoma, 273-275
clinical manifestations, 682-683
Epidermal cells, 237-239 Herbs, medicinal, 842
contagion, 683-684
Epidermolysis bullosa acquisita, 37-40, Hereditary benign telangiectasia, 307
cosmesis, 683
689 Hereditary hemorrhagic telangiectasia,
goals of therapy, 683-685
Epidermolysis bullosa simplex, 500 307, 309
Erythromycin, 131-133, 842 methods of treatment, 769-775 Herpes, genital, 399
and warts, 558 Herpes gladiatorum, 49
Erythropoietic porphyria, 530-531
Esophageal manifestations, in Gentian violet, 210-212 Herpes simplex, 298-299, 454
Geographic tongue, 368-369
autoimmune bullous diseases, Herpes zoster, 672, 745-746
687-690 Gingivitis, 377 disseminated, 55-56
Esophagitis dissecans superficialis, 687 Glandular activity, during pregnancy, 377 Hirsutism, 376
Ethics, of organ transplantation, 691 Glandular secretions, 362-363 Histamine-independent pathway, 206-209
European Academy of Dermatology and Glasgow University, 733-735 HIV infection
Venereology, 41 Gloves, surgical/examination, 853-854 and Buruli ulcer, 744
Euthyroid pretibial myxedema, 431-432 Glucocorticosteroids, 149-151, 181 hair and nail disorders associated
Evans’ syndrome, 142 Glucose-6-phosphate deficiency, 745 with, 453-456
Exercise, 837 Gnathostoma hispidum, 175-177 HIV-1, 89
898
Subject Index
and molluscum contagiosum, 142-144 Infection Keratinocytes, 103-105
and porphyria cutanea tarda, erythromycin vs. cefadroxil, 131-133 Keratitis, ichthyosis, and deafness (KID)
435-436, 474-479
fungal, 558 syndrome, 58-59
see also AIDS gentian violet and brilliant green Keratoacanthoma, 777-778
Hodgkin’s disease, 791-792 against microorganisms Keratoderma, 369-370
Hodgkin’s lymphoma, 351-352 associated with, 210-212 Keratosis follicularis, 351
Hopital Saint Louis, 134-136 and occlusive dressings for wounds, Kerion, 66
11-13
Hormones Ketoconazole, 58-59, 511-512, 842
and cutaneous hyperpigmentation, 462 ofloxacin vs. cephalexin for treating KID syndrome see Keratitis, ichthyosis,
skin and soft tissue, 443-445
and dermal connective tissue, 149-151 and deafness (KID) syndrome
post-excisional of wounds, 359-360
in postmenopausal androgenetic Kuwait Society of Dermatologists,
alopecia, 858-859 staphylococcal, 631 821-822
sex, 118 Insect bites, 559 Kveim-Siltzbach test, 387
HPV infection see Genital human Interferon, 434, 773-774, 813-816 Kyrle disease, 117-118
papillomavirus infections intralesional injection of, 894
HTLV-1 see Human T-cell lymphotropic International Congress of Dermatology
virus type I and Syphilology, 136-138 Langerhans’ cells, 164
Human immunodeficiency virus infection International Foundation for La Plata (Arg.), 886
see HIV infection Dermatology, 739 Lasers, 473, 601-607, 772-773
Human papillomavirus infections see International Journal of Dermatology,
Launois-Bensaude syndrome see Multiple
Genital human papillomavirus editorial, A6
symmetric lipomatosis
infections International Society of Dermatology:
Human T-cell lymphotropic virus type | Tropical, Geographic and Leeches, 285
(HTLV-1), 582-586 Ecologic, 71-72, 364, 889 Leg
Hydrocolloids, 12 Intestinal lymphoma, 178-179 elephantiasis, 847-848
Hydrocortisone, 264 Intralesional corticosteroids, 233-234 ulcers, 511-512
Leishmaniasis, 562-563,
Hydrogels, 12 Intravascular papillary endothelial
hyperplasia, 713-714 Lentiviruses, 89
Hyperbaric oxygen therapy, 594-596, 757
Iritis, 672 Lepromatous leprosy, 813-816
Hyperkeratosis nigricans, 524
Hyperkeratotic nodules, 117 Iron, 535 Leprosy, 66-67, 165 §03-504,
§51-55 34, 813-816,
Hypermelanosis, 345-347 Isotretinoin, 199-200, 371 887-888. 891-892
long-term use, 367-368
Hyperpigmentation, 375, 458-463, 524 Lesions
Hyperplasia, 713-714 Itch see Pruritus
cutaneous in lupus erythematosus, 266
Itraconazole, 805-811
Hypertension, 382 facial pyogenic granuloma-like,
Hyperuricemia, 381 199-200
Hypomelanosis of Ito, 284-285 morphology of pigmented skin, 619
Japanese Dermatological Association, 147 roseolar in Lyme disease, 507-508
Japanese Society for Medical Mycology, of skin and acquired perforating
Idiopathic urticaria, 29, 355-356 669 dermatosis, 201-204
IgA, 343-344, 709 Japanese Society of Pediatric of skin in Filipino elderly, 196-198
Dermatology, 296
IgE, 581 specific cutaneous in CD8+ peripheral
IgM, 432 Jaundice, 376 T-cell lymphoma, 624-628
Impetigo, 1-7 Joints, 488-491 Leukemia, 582-586, 598-599
Immune system, 470, 551-552, 599-600 Leukodermic macules, 715-717
Immunobullous diseases, 521 Leukoplakia, 301-304
Immunochemistry, 625 Kaposi’s sarcoma Levodopa, 316
Immunofluorescence, 38, 191, 265 AIDS-related, 471 Lichen amyloidosus, 95-97, 747
Immunomodulators, 154 cutaneous Cryptococcosis mimicking, Lichen planus
Incontinentia pigmenti achromians 279-280 and hypertension, 382
see Hypomelanosis of Ito following renal transplantation, impaired carbohydrate metabolism,
India 439-440 381
cutaneous lupus erythematosus in, in 1973, 598 and liver, 380-381, 392-394
265-268 Keloidal scleroderma, 422-423 melasma-like actinic, 413-415
mudi-chood in, 396-397 Keratin, 500 and neurologic disorders, 382
International Journal of Dermatology
Vol. 31, No. 12, December 1992
pathogenesis and associated diseases, Microcirculatory disorders, 833-834 wrapping, 679
379-382 Microsporum canis, 228, 367 yellow, 454
pigmentosus, 87-93 Microwave dressings, 660-663 National Skin Centre (Singapore), 555-559
and psoriasis, 382 Migratory panniculitis, 424-425 National Student Research Forum,
Lie detector, 855 Milia, 793-794 866-867
Light microscopy, 481, 618-620, 625 Mini-mycetoma, 180-181 Nd:YAG (neodynium yttrium aluminum
Lindane, 357-358 Minoxidil 2%, 800-804 garnet) laser, 604-605
Lipomatosis, 80-82 Mite, 525 Nerves, 552-553
Lithium carbonate, 368-369 Mohs micrographic surgery, 83-85 Neural crest, 293
Liver, 380-381, 392-394, 404-408 Molecular biology, 416 Neurofibromatosis, 344
Loose anagen hair syndrome, 107-108 Molluscum contagiosum, 142-144 Neurologic disorders, 382
Loratadine, 355-356 Monoclonal antibodies, 410-411 Neuropeptides, 552-553
Lorenzo the Magnificent, 778 Morphea, 190-192 Neutrophilic dermatosis, 645-648,
Louis-Bar syndrome Mosaicism, 345-347 864-865
see Ataxia-telangiectasia Moulage, 134-141 Neutrophils, 670-671
Loxosceles reclusa, 652 Mucinosis, 649-651, 791-792 Nevoid hypermelanosis, 345-347
Lupus erythematosus Mucous membrane, 377 Nevus cell, 291-293
cutaneous, 260-263, 265-268 Mudi-chood, 396-397 Nifedipine, 29
discoid, 182-183 Muller’s phlebectomy, 837 Nitro compounds, 462
familial, 819-820 Multiple myeloma, 424-425 Nocardia asteroides, 178-179
subacute, 165 Multiple symmetric lipomatosis, 80-82 Nocardia brasiliensis, 180-181
systemic, 142, 653-656, 804, Mupirocin Nodular (keloidal) scleroderma, 422-423
819-820 Nonbullous bullous pemphigoid,
topical for post-excisional wound
vesiculobullous, 793-794 498-500
infection, 359-360
Lupus verrucosus, 737 in treatment of impetigo, 1-7 Nonfilarial elephantiasis, 849-851
Lyme disease, 507-508 Mycoses, 725-729 Notalgia paresthetica, 166, 370
Lymphatic filariasis, 846-847 Mycosis fungoides, 522 Nursing, in space, 220-221
Lymphedema, 660-663 Myelodysplastic syndrome, 647-648, Nutritional support, for toxic epidermal
Lymphocutaneous nocardiosis, 178-179 864-865 necrolysis, 757-
Lymphocytes, 470 Myeloma, 424-425
see also T-lymphocytes multiple, 297-298
Lymphokines, 154 Myiasis, 657-659 Obituaries
Lymphoma, 582-586, 624-628, 789-790 Mycobacterium marinum, 286-287 Canizares, Orlando, 666-668
Myotonic dystrophy, 348-350 Derbes, Vincent J., 147
Myxedema, 431-432 Rook, Arthur J., 365-366
Macular amyloidosis, 95—97, 277-278 Occlusive dressings, 10-14
Malakoplakia, 483 Occult syringoma, 437-438
Malaysia, bullous diseases in, 42-45 Naftifine, 247-248 Ofloxacin, 443-445
Malignancies Nails Onchocerciasis, 848
multiple dermal cylindroma, 642-644 changes during pregnancy, 376 Onychomycosis, 453-454, 680, 861
perineural invasion by, 83-85 and chronic renal failure, 861 Onychoscizia, 680
Spitz nevus, 639-641 conditioners, 678 Ophthalmic care, for toxic epidermal
necrolysis, 759
sunscreens, UVA, and cutaneous, cosmetics of, 675-680
544-547 Oral hairy leukoplakia, 301-304
accessories, 679
Malignant atrophic papulosis, 99-102 implements, 679 Ort, 164
Medical licensing examination, 798-799 preparations, 677-679 Organ transplantation, 691
Melagenina, 314 therapy for abnormalities, 679-680
Melanoma, 525, 629-631 enamel removers, 675, 678 Pachydermodactyly transgrediens,
796-797
Melasma, 375-376, 413-415 enamels, 677
Mendoza (Arg.), 885-886 hardeners, 676, 678 Pachydermoperiostosis, 341-342
Mercury, 159, 353-354, 438 and HIV infection, 453-455 Palmar erythema, 377
Methotrexate, 404-408 sculpted, 678-679 Panniculitis, 424-425
900
Subject Index
Papillary endothelial hyperplasia, tetracyclines, 459-460 Primary thymic carcinoma, 426-428
713-714 and toxic pustuloderma, Progressive systemic sclerosis, 257-259
Papillomatosis, 480-482 venoactive, 837 Prostaglandin inhibitors, 314
P>a. pillomaavvi rus inf=ec tions s. ee Gen. ital see also specific drugs and drug types Prostate adenocarcinoma, 647- -648
human papillomavirus
pap Phenothiazines, 463 Protein kinase A,
infections
Phenylalanine, 317 Protein kinase C,
Papulonodular cutaneous mucinosis,
Phenytoin, 730-732 Pruritus, 236, 409, 747,
649-651
Phlebology, 833-838 861-862
Paracoccidioidmycosis, 726, 728, 729
Pseudodiphalia, 119-121
Photodermatitis, 372
Passive transfer, 470 aie
r Pierini, Luis E., 882-883 . Psewuadoap hantom - itc—h, 856,- 857
Patient communication, 200 |
x = . *soriasiform sarcoidosis, 339-340
Pelgeroid-lik tls, 864-865 Pislets, 631 a
e gerol “like anomalous Cells . - 5 -_ Pps oriasis, 5e5ro8
= Pigment-colorants, 678
Pellagra, 724 and aminophyllin, 370-371
P higoid Pigmented angiodermatitis, 786-787 ‘
emphigoi i ad TE and anthralin,6 7
Pilomatricomas, 348-350, 703-705
bullous, 37-40, 498-500, 689 p anthralin short-contact therapy,
ityriasis
cicatricial, 688-689 126-129
= alba, 525-526 =
in Malaysia, 42-45 azathioprine for, 873
vesicular, 868-870 rpoatnuan da, 745 and calcipotriol, 5‘ 49
Pemphigus P>l asmaphere—s is, 758 and cyclosporine, 521, 8
Plasticizers, 677 , :
drug-induced, 67-68 ‘ fish oil in, 863
Plastic surgery, 222 ; 4
foliaceus treated with plasma 5 and HIV infection, 454
exchange, 87-_1 -87-2 P>o doconiosis, 85 851 and joint complai, nts, 488-491
herpetiformis, 144 Podofilox, 769-770 and leprosy, 551-553
. ) 769-77 =
in Malaysia, 42-45 Podophyllin, 76 0 and lichen planus, 382
two-step induction by ACE-inhibitors, Poikiloderma, 277-278 methotrexate-treated, 404-408
33-36 Polyglandular autoimmune syndrome, pattern of 50 kd cytokeratin, 30-32
vulgaris, 46-51, 67-68, 687-688, 343-344 research in China, 840-843
875-877 Polygraph, 855
and warfarin, 743-744
Poenniicc illium marneffeSio, 410-411 ‘ P-oollyymmyyocs itis, 867 Psoriatic epidermal cells, 2273 7-23999
Penis, elephantiasis ot,. 848 P>o roke. ratosis Puncta pruritica, 166, 370
Pentoxifylline, 747 and immunosuppression, 673, Pure red cell aplasia, 426-428
Perf: orating disorders, 11~ 7-118, 201-204, 781'- 782 Purpura
862 of Mibelli, 52-54
tactitious, 169-170
Perifolliculitis capitis abscendens et Porphyria cutanea tarda, 435-436,
and Strongyloides hyperinfection,
suffodiens, 746 474-479 169-170
PPeerriinpehuerraall Ti-ncvealsli onl,y m8p3h-o8m5a , 624-628 PPoosrtp-hkyarliaa-sa,z ar5 27d-e5r m2a5 6l leishmaniasis, P>u rpuric poigpmeennte d angiodermatitis,
Mi 400-403 ; oo
Peripheral T-lymphocytes, 110-111 Pustuloderma, 172-173
Post-viral chronic active hepatitis, 393
Permethrin, 357-358 Pyoderma gangrenosum
Persian Gulf War, 494-497 Prednisolone, 513-516 and antiphospholipid antibodies,
Preformed plastic nails, 678 See seq
Peru, skin disease in, 560-561 P ves-S8
Petechiae, 169-170 PIrree gnancy associated conditions, co 574--5—7 6
Phensoen iach. 856-857 and follicular mucinosis, 441-442 treatment with clofazimine, 591-593
cn, a.
physiologic skin changes associated treatment with hyperbaric oxygen
Pharmaceutical industry, 144 a
bh with, 375-378 therapy, 594-596
Pharmacologic agents
BK a6 - Prepubertal erythropoietic porphyria, Pyogenic granuloma-like lesions,
antimalarials, 458 §30-531 199-200
chemotherapeutic, 460-462 Pretibial myxedema, 431-432
cutaneous hyperpigmentation caused Primary biliary cirrhosis, 392, 393-394
by 9 sy. ste>m ic,- 4558 -463 Primary localized cutaneous amyloidosis,
Quiroga, Marcial I., 882-884
dermal connective tissue modulated 94
by, 149-154 Primary sclerosing cholangitis, 392, 394
and FDA, 691-692 Primary telangiectasia of childhood,
generic, 893 307-312 Radon dermatitis, 214-217
International Journal of Dermatology
Vol. 31, No. 12, December 1992
Recessive dystrophic epidermolysis Skin Sudan, post-kala-azar dermal
bullosa, 730-732 anatomy, Cowper’s, 361-363 leishmaniasis in, 400-403
Recombinant interferon gamma, 813-816 disease, 112, 555-561 Sun exposure, 298-299, 524
Red cell aplasia, 426-428 health care, 416-421 Sunscreens, 540-547
Reiter’s syndrome, 454 and smoking, 779-780 Surgery
Renal failure, 117-118, 860-862 see also specific conditions and and Behcet’s disease, 571-572
Renal transplantation, 439-440 diseases for genital HPV infection, 771
Reply Smoking, 508, 779-780 glov es, 853-854
to Professor Barth, 67 Sociedad Argentina de Dermatologia, laser, 606
to Dr. Katayama, 165 884, 887 Mohs micrographic, 83-85
Retinoids, 151-152 Society News senior medical student clinical and
Rhaboid tumors, 484—486 alopecia areata, 73 research electives, 288-290
Rhinophyma, 32 International Society of Dermatology: in space, 220
Rickettsiae, 823 Tropical, Geographic and subspecialty electives, 472-473
Ecologic, executive
Riyadh (Saudi Arabia), 565-567 venous, 837-838
committee meeting, 364
Rosario (Santa Fe; Arg.), 885 Sutures, 248
international sponsorship program, 73
Rothmund-Thomson syndrome, 311-312 Sweet’s syndrome see Acute febrile
invitation to the regional meeting, 889
Ruby laser, 604 neutrophilic dermatosis
news from the international league, 73
Synthetic dressings, 10-15
obituary: Arthur J. Rook, 365
Syphilis
obituary: Vincent J. Derbes, 146
and AIDS, 156
Salta (Arg.), 886 Orlando Cafiizares —as I remember
medieval treatment of, 272
Saperconazole, 725-729 him, 666
origin of, 294
Sarcoidosis, 339-340, 385-388 Orlando Cajfiizares and Latin
and mercury, 438
Saudi Arabia American dermatology, 667
in 16th century, 109
cutaneous leishmaniasis in Riyadh, report from the International
565-567 Foundation for Dermatology, Syringoma, 437-438
white piedra in, 501-502 739 Systemic antimicrobials, 758-759
Scabies, 357-358, 525, 736 the International Society of Systemic lupus erythematosus
Dermatology: Tropical, see Lupus erythematosus
Scalp, 348-350
Geographic and Ecologic, 71
Scientific review, 564 Systemic mycoses, 725-729
update in tropical dermatology, 889
Scleroderma, 422-423, 819-820
Solvent extenders, 678
Sclerosing cholangitis, 392, 394
Space Dermatology Foundation, 218-222
Sclerosis, systemic, 451 Tartar emetic, 269
Space stations, 219-220
Sclerotherapy, 837 T-cell lymphoma, 582-586, 624-628
Specialists, medical, 330
Scorbutic ulcers, 717 T cells, 321-325
Spider bites, 652
Scrotum Telangiectasia
Spider telangiectasia, 309-310
calcinosis of, 75-79 generalized essential, 309
Spine, 505-506
elephantiasis of, 848 hereditary benign, 307
Spitz nevus, 639-641
Scrub typhus see Tsutsugamushi disease hereditary hemorrhagic, 307, 309
Sporotrichosis, 726
Sculpted nails, 678-679 nomenclature of primary, 320
Squamous cell carcinoma, 492-493,
Scurvy, 644, 659, 724, 844, 872 577_778 primary of childhood, 307-312
Sebaceous gland, 377 Staphylococcal infection, 631 Telogen effluvium, 376
Seborrheic dermatitis, 795 Staphylococcus aureus, 700-702 Terbinafine, 720-721
Secondary intention healing, 185 Steroids Terfenadine, 355-356
Semipermeable films, 12 Tetracaine, topical liposomal, 894
porphyrinogenic, 531
Senile pruritus, 856-857 systemic, 234-235 Tetracyclines, 449-460
Sex hormones, 118 topical, 231-233 B-Thalassemia intermedia, 747-748
Sézary syndrome, 522 Striae distensae, 376 Thalidomide, 599-600
Sheehan’s syndrome, 182-183 Strongyloides hyperinfection, 160-162, Thermoplastic resin, 677
Sheep, orf in, 164 169-170 Thiopronine, 722-724
Signal transduction, 237-239 Subcutaneous mycoses, 725-729 Thymic carcinoma, 426-428
Sjégren’s syndrome, 165 Substance P, 206-209 Tinea capitis, 66, 367, 455
902
Subject Index
Tinea pedis, 861 Tunable dye laser, 603-604 nonsegmental, 321-325
Tinea versicolor, 253-256, 664-665 Typhus disease group, 823-831 and polyglandular autoimmune
T-lymphocytes Tyrosine kinase, 237, 238 syndrome, 343-344
peripheral, 110-111, 321-325 Von Recklinghausen’s neurofibromatosis,
relevance of current studies to 344
dermatology, 157-158
Ulcers
Toe web studies, 784 Buruli, 25-26
Toluene-sulfonamide formaldehyde resin, decubitus, 412 Warfarin, 743-744
675 leg, 511-512, 747-748 Warts, 777
778, 870
Tongu6 e, 368-369 and psoriasiform sarcoidosis, 23203 9-324 0 Y mar ee
' and genital HPV, 558
Topical corticosteroids, 241, 264 —
. scorbutic, 71 Waasssseerrmms ann *stte.st, 156
Topical steroids, 231-233 4 ‘ . ‘
trophic, 503-504 : :
. Wax dermatologic modeling, 134-141
Toronto (Canada), granuloma inguinale Ultrasound. 404-408
in, 696-698 kf . i = wae Weil-Felix test, 830
Ultraviolet A (UVA), 544-54
Toxic epidermal necrolysis, 749-760 imbil 697 Wells’ syndrome see Eosinophilic cellulitis
mbilicus,
causes, 749-751 P : i White piedra, §01-502
nilateral Darier’s disease, 351
clinical manifestations, 751 : 4 Women
niversity College Hospital, 446-450
demographics, 749 . androgenetic alopecia, 800-804
erap niversity of El Salvador, 884 ee
differential diagnosis, 753, P 754 J rolithiasis, 38”1 andd clcilniinci cal trialsa,l s, 81871
histopathology, 752-753 Urticaria. 29, 355-356. 8 in med" icine,» 2P8R23
history, 749
Wounds
laboratory » tetessts. ts, 7527 52 chronic, 14-15 ‘
management, 755-760 : ~ dressings, 10-15
a Vaccination, typhus, 83
pathogenesis, 753-755 and infection
. Toxic pustuloderma, 1=7 2-17-3 Varicose veins, 834-835 o: cclusive. 10 ’
as POS Varicosities, 3 ae .
Trace elements, 525-526 s : " i heal. 25
1 1-677 Vascular derivation, 165-166 Rate 00 Res, Le
raction, 6/1-6/72 .
‘ : sie Vascular spiders, 377 miscellaneous superficial, 13
ransplantation, 673, 6 2<o 2
d -— Venereal disease post-excisional infection, 359-360
Trichloroacetic acid, 770 ; pie
a s clinics, 350 rational approach to care, 27-28
Trichophyton antigen, 122-125 :
a: see also Syphilis topical agents in management, 15
Trichorhinophalangeal syndrome, 706-708 , aa =e
ms e e Venoactive drugs, 83 work of Bruno of Longoburgo, 573
Trophic ulcer, 503-504 ; ea =
vt Venous insufficiency, 833-834, 836-8 see also Burns
T6 antigen, 103-105 ass
Vesicular pemphigoid, 868-870
Tsutsugamushi disease, 693-695, 829-831 :
Vesiculobullous iupus erythematosus,
Tuberculosis 793-794
cutaneous, 110-111, 505-506 Xanthoma disseminatum, 281-282
Vienna moulage tradition, 138-141
verrucosa cutis, 503-504 Virol waste, $58
Tucuman (Arg.), 886 Vitamin C. 151
Tumors Vitiligo Zagazig International Conference of
cutaneous, 377-378 in children, 621-623 Dermatology and Venereology,
rhabdoid, 484-486 non-psoralen treatment, 229-2352¢, 74400.-7744)2
see also Lesions 314-318 Zidovudine, 454
International Journal of Dermatology
Vol. 31, No. 12, December 1992
AUTHOR INDEX Barrientos, Alberto, 297 Casas, M.A. Sola, 277
Barth, Joachim, 67, 740 Catsman-Berrevoets, Coriene E., 249
Abahussein, Abdulaziz A., 730 Baruah, M.C., 503, 621 Cauwenbergh, Gert, 805
Abdel-Naser, M. Badawy, 321 Bashi, Edna, 511 Cernea, Selma S., 260
Abrahamian, Lori M., 307 Beer, Robert E., 637 Cervera, Ricardo, 624
Abrams, Beatrice B., 122 Beightler, Eloise L., 160, 169 Chamuleau, Rob A.F.M., 404
Abson, Kim G., 453 Benedetto, Anthony, 218 Chan, H.L., 426
Adam, Basheer A., 42 Benedetto, Ernest, 437 Chang, Ann, 747
Agolzer, Antonina, 507 Benrimoj, Shalom I[., 1 Chang, Patricia, 117, 180
Aguilar, Antonio, 713 Beranek, Jiri T., 165 Chaudhuri, Siba P. Ray, 270
Ahmad, Manzoor, 703 Bergfeld, Wilma F., 437 Chikakane, Kenichiro, 184
Ahmed, Hyder M.A., 400 Bernabo, Jorge, 813 Choi, Eung Ho, 578, 649
Ahmed, Mousa, 525 Bernal, J.E., 599 Chorzelski, Tadeusz, 144, 190
Ahn, Sung Ku, 578 Bernhard, Jeffrey D., 856 Chow, P., 635
Aksakal, Burhan, 571 Besuschio, Santiago, 813 Chua-Ty, G., 555
Alaibac, Mauro, 157 Beutner, Ernst H., 37 Chung, Kee-Yang, 649
Albert, Lee S., 331 Bhattacharya, Sambit N., 110, 632 Cinco, Marina, 507
Alberto, Nenita L., 196 Binkley, Karen, 611 intin, Christina, 871
Alcacer, Javier, 791 Bissonnette, Robert, 172 ipollaro, Vincent A., 666
Alcalay, Joseph, 637 Bittencourt, Achiléa L., 568 laudy, Alain L., 286
Alejo, Maria, 422 Blaisdell, Jodi Matsuura, 273 lotet, Bonaventura, 193
Alessi, Elvio, 351 Blauvelt, Andrew, 279, 474 ockerell, Clay J., 615
Alexander, John O’D., 733 Booth, Jane H., 1 ohen, Ernst B., 404
Ali, Mohamed S., 400 Bordignon, Gisele F., 805 ollins, N., 398, 635
Allaire, Guy, 172 Bottasso, Oscar, 813 orreia, Osvaldo, 517
Allen, Bernard R., 520 Boyd, Alan S., 284, 370, 823 osta, Jackson M.L., 568
Allen, Samuel, 744 Bozkurt, Meral, 571 ottoni, Francesca, 745
Alster, Tina S., 601 Brenner, Sarah, 298, 341, 431, 511 owen, Peter, 336
Aly, Raza, 122 Brook, Itzhak, 700 rissey, John Thorne, 166
Amamiya, Shin, 345 Brown, Patricia C., 201 uevas, E. Jorda, 119
Amara, Ingrid, 878 Bruce, Suzanne, 594 zarnecki, D., 359, 398, 492, 635
Amer, Mohamed, 357, 821 Brunet, Salut, 647
Amichai, Boaz, 718 Brunetti, B., 895
Ando, Katsuhiko, 175, 693 Buck, H. William, 657 Dabelsteen, Erik, 871
Antoniou, Christina, 664 Buenida-Teodosio, Gracia, 196 Das, Siddhartha S., 875
Arenas, Roberto, 87, 90 Bunker, C.B., 446 David, Michael, 199, 687, 746
Armijo, Miguel, 706 Burgos-Calderon, Rafael, 860 Davis, Ira C., 540
Asahina, Akihiko, 868 De Angelis, Ernest, 722
Ataoglu, Omiir, 571 Dechner, Edit, 498
agliani, Paola, 351 Dekoven, Joel, 696
ainelli, Tullio, 126 Delfino, M., 895
Babe, Kenneth S., Jr., 588 allen, Jeffrey P., 441
Delgado, Luis, 517
Badaro, Fernando, 568 ‘ahizares, Orlando (Deceased), 71, Del Rio, Emilio, 297, 713
Bakker, Peter, 210 -appugi, Pietro, 206 Demitsu, Toshio, 99
Balsa, José, 343 aputo, Ruggero, 73 De Moragas, José M., 422, 435, 647
Bang, Dongsik, 578 arlotti, A., 67 Denis, Marcelle, 286
Barnadas, Maria A., 647 arney, James F., 58 Diven, Dayna G., 160, 169
Barnett, Jay M., 675 arrasoo, Daniel, 372 Dobak, John, 544
Barral, Aldina, 568 arrel, Claude-France, 126 Dominguez-Soto, Luciano, 87, 90, 372
Barral-Netto, Manoel, 568 Carroll, Cezanne, 353 66
Barranco, Juan Carlos, 193 Cartone, Carmela, 37 Don, Philip C., 793
Barranco, Vincent P., 452, 691 Carver, Nigel, 10 Dorman, Tony, 75